Intravenous immunoglobulins modify the response to erythropoietin in a CAPD patient.
al Shohaib
S
S
Abunijem
Z
Z
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D002648:Child; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000008:administration & dosage; D007275:Injections, Intravenous; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000628:therapy; D008181:Lupus Nephritis / Q000150:complications; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D011994:Recombinant Proteins
D007136:Immunoglobulins; D011994:Recombinant Proteins; D004921:Erythropoietin